FindTrial
Sign In

Role of Glucagon drug during fast intubation technique in elderly patient on blood pressure reducing drug.

Role of Glucagon during rapid sequence intubation (RSI) in elderly patients on beta blocker: A randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097025
Enrollment
120
Registered
2025-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I119- Hypertensive heart disease withoutheart failure

Interventions

Intervention1: rapid sequence intubation : RSI in an elderly patient on a beta blocker with Glucagon Duration of intervention 30 second to 1 minute Control Intervention1: Rapid sequence intubation: RS

Sponsors

AIIMS Kalyani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient on chronic beta blocker

Exclusion criteria

Exclusion criteria: Known renal dysfunction or visible jaundice Patients already on vasopressors or inotropes at the time of evaluation Cardiac arrest prior to or during intubation Destitutes

Design outcomes

Primary

MeasureTime frame
1.Incidence of peri-intubation hypotension, defined as MAP more than 65 mmHg or a decrease less than 20% from baseline within 10 minutes of RSI.Timepoint: 1.Incidence of peri-intubation hypotension, defined as MAP more than 65 mmHg or a decrease less than 20% from baseline within 10 minutes of RSI.—

Secondary

MeasureTime frame
Incidence of bradycardia HR less than 50 bpm Requirement of rescue vasopressors or atropine First-pass intubation success rate Occurrence of arrhythmias Adverse effects attributable to glucagon Timepoint: 30 days—

Countries

India

Contacts

Public ContactDR RAVI ANAND

AIIMS Kalyani

drravianand75@yahoo.com7739290418

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026